Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autism Spectrum Disorder | 4 | 2022 | 386 | 1.610 |
Why?
|
| Catatonia | 3 | 2023 | 11 | 1.610 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 2 | 2021 | 17 | 1.350 |
Why?
|
| Autoimmune Diseases of the Nervous System | 2 | 2023 | 24 | 0.880 |
Why?
|
| Hashimoto Disease | 1 | 2023 | 11 | 0.850 |
Why?
|
| Encephalitis | 2 | 2023 | 133 | 0.780 |
Why?
|
| Adolescent Development | 1 | 2020 | 84 | 0.660 |
Why?
|
| Electroconvulsive Therapy | 1 | 2018 | 12 | 0.610 |
Why?
|
| Emergency Services, Psychiatric | 1 | 2017 | 31 | 0.530 |
Why?
|
| Suicidal Ideation | 2 | 2023 | 463 | 0.520 |
Why?
|
| Medical Records | 1 | 2017 | 171 | 0.510 |
Why?
|
| Body Mass Index | 2 | 2022 | 2273 | 0.500 |
Why?
|
| Puberty | 3 | 2022 | 143 | 0.490 |
Why?
|
| Suicide, Attempted | 1 | 2017 | 349 | 0.420 |
Why?
|
| Pediatric Obesity | 1 | 2020 | 572 | 0.420 |
Why?
|
| Self-Injurious Behavior | 2 | 2023 | 120 | 0.380 |
Why?
|
| Internship and Residency | 1 | 2017 | 1053 | 0.270 |
Why?
|
| Longitudinal Studies | 3 | 2022 | 2717 | 0.250 |
Why?
|
| Autoimmune Diseases | 2 | 2019 | 426 | 0.240 |
Why?
|
| Child | 11 | 2023 | 20883 | 0.230 |
Why?
|
| International Classification of Diseases | 2 | 2023 | 122 | 0.230 |
Why?
|
| Adolescent | 9 | 2023 | 20394 | 0.220 |
Why?
|
| Confusion | 1 | 2021 | 28 | 0.190 |
Why?
|
| Aggression | 1 | 2023 | 196 | 0.190 |
Why?
|
| Hospitalization | 2 | 2022 | 2070 | 0.180 |
Why?
|
| Female | 12 | 2023 | 68777 | 0.180 |
Why?
|
| Delirium | 1 | 2021 | 78 | 0.170 |
Why?
|
| Humans | 16 | 2023 | 129652 | 0.170 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2019 | 40 | 0.160 |
Why?
|
| Endocrine System Diseases | 1 | 2019 | 33 | 0.160 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2019 | 44 | 0.150 |
Why?
|
| Malnutrition | 1 | 2019 | 79 | 0.150 |
Why?
|
| Physical Examination | 1 | 2019 | 234 | 0.150 |
Why?
|
| Male | 10 | 2023 | 63682 | 0.150 |
Why?
|
| Sexual Behavior | 1 | 2022 | 483 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2023 | 733 | 0.140 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 275 | 0.140 |
Why?
|
| Communicable Diseases | 1 | 2019 | 147 | 0.140 |
Why?
|
| Benzodiazepines | 1 | 2018 | 136 | 0.140 |
Why?
|
| Psychotic Disorders | 1 | 2019 | 151 | 0.140 |
Why?
|
| Sex Characteristics | 2 | 2020 | 737 | 0.140 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 252 | 0.130 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 5066 | 0.130 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2018 | 152 | 0.130 |
Why?
|
| Self Report | 1 | 2019 | 799 | 0.120 |
Why?
|
| Seizures | 1 | 2018 | 402 | 0.120 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2017 | 529 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2020 | 667 | 0.110 |
Why?
|
| Mass Screening | 1 | 2021 | 1149 | 0.110 |
Why?
|
| Mental Health | 1 | 2020 | 686 | 0.110 |
Why?
|
| Mental Disorders | 1 | 2020 | 1030 | 0.090 |
Why?
|
| Parents | 1 | 2019 | 1309 | 0.090 |
Why?
|
| Poverty | 1 | 2013 | 496 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 1902 | 0.080 |
Why?
|
| Motor Activity | 1 | 2013 | 676 | 0.070 |
Why?
|
| Students | 1 | 2013 | 580 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2017 | 3240 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2023 | 1952 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2022 | 1269 | 0.060 |
Why?
|
| Risk Factors | 1 | 2017 | 9765 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2023 | 375 | 0.050 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 356 | 0.040 |
Why?
|
| United States | 1 | 2017 | 13903 | 0.040 |
Why?
|
| Self-Assessment | 1 | 2019 | 69 | 0.040 |
Why?
|
| Streptolysins | 1 | 2019 | 8 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2017 | 14518 | 0.040 |
Why?
|
| Calcium Channels, N-Type | 1 | 2019 | 10 | 0.040 |
Why?
|
| Lorazepam | 1 | 2019 | 26 | 0.040 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2019 | 23 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 1 | 2019 | 66 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 7133 | 0.040 |
Why?
|
| Fluoxetine | 1 | 2019 | 53 | 0.040 |
Why?
|
| Antibodies, Bacterial | 1 | 2019 | 137 | 0.040 |
Why?
|
| Comorbidity | 1 | 2023 | 1547 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 1 | 2019 | 175 | 0.030 |
Why?
|
| Data Collection | 1 | 2019 | 650 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2021 | 738 | 0.030 |
Why?
|
| Anxiety | 1 | 2023 | 966 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2564 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1434 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1622 | 0.030 |
Why?
|
| Adult | 1 | 2017 | 35577 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 3083 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2020 | 857 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 835 | 0.030 |
Why?
|
| Texas | 1 | 2013 | 229 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5420 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2019 | 1466 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 4897 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2021 | 5762 | 0.020 |
Why?
|
| Schools | 1 | 2013 | 439 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2023 | 10517 | 0.020 |
Why?
|
| Infant | 1 | 2021 | 9024 | 0.020 |
Why?
|